supply of coronary drug eluting stents. stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm ., ( sr ph code 153042 ) coronary drug eluting stents with ( 1 ) stent on cobalt chromium alloy or platinum chromium alloy. ( 2 ) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia ) ( 3 ) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. ( 4 ) the strut thickness should be 91 micron or less. ( 5 ) stent delivery system should be monorail ( single operator exchange or rapid exchange ) . ( 6 ) stent should be compatible with 5fr guiding catheter ( 7 ) stent design should be open cell type. ( 8 ) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. ( 9 ) the long term efficacy and safety of the stent in terms of target vessel revascularisation ( tvr ) and in-situ thrombosis ( ist ) should be documented / published in peer reviewed scientific journals. ( 10 ) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid ( 11 ) the manufacturer / supplier should submit proof of supply of the stent to a major government institute. unit:no